DAIC

JUNE 11, 2024

“With the Genesis RMN system, we now have an unprecedented level of precision and control during cardiac ablation procedures, allowing us to target arrhythmias with unmatched accuracy while minimizing risk to our patients.” We are proud to lead the way in Italy, revolutionizing cardiac treatment through innovative robotic technology."

Heart Rhythm 81

Heart Rhythm Technology Electrophysiology Arrhythmia 81

DAIC

JULY 24, 2024

Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. FDA 510(k) clearance and European CE Mark approval for its innovative products. The company has obtained U.S.

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

DAIC

FEBRUARY 27, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , announced the commencement of patient cases with the investigational Laminar Left Atrial Appendage Elimination (LAAX) System as part of its pivotal investigational device exemption (IDE) study. The acquisition of Laminar, Inc.

Atrial Fibrillation 105

Atrial Fibrillation Innovation AFIB Pharmacology 105

DAIC

MAY 21, 2024

Stereotaxis will present an innovative proposal leveraging advanced robotic technology and telerobotic presence to sustainably offer high-quality cardiac ablation therapy in underserved regions of Africa. When left untreated, arrhythmias may significantly increase the risk of stroke, heart failure, and sudden cardiac arrest.

Heart Rhythm 52

Heart Rhythm Innovation Electrophysiology Technology 52

DAIC

JUNE 25, 2024

This AI technology can detect 35 cardiac determinations (14 arrhythmias and 21 morphologies), including serious conditions like acute myocardial infarction ( MI ) and the most common types of cardiac ischemia, using a reduced leadset. KAI 12L employs multiple deep neural network algorithms, trained and validated on more than 1.75

Technology 116

Technology Heart attacks Heart Attack Innovation 116

DAIC

DECEMBER 27, 2023

With the unveiling of the Genesis System, Baptist Health Lexington has become the first in Kentucky, and one of the first in the world, to provide the latest advancement in robotic technology to treat cardiac arrhythmias. “We In 2006, Lewis realized something was not right with his heart during one of his regular outdoor runs.

Technology 105

Technology Heart Disease Heart Rhythm Arrhythmia 105

DAIC

JANUARY 3, 2024

The Zio monitor ECG System secured its CE mark based on compliance to EU MDR standards of performance, quality, safety, and efficacy, along with the body of clinical evidence supporting Zio in detecting potential cardiac arrhythmias. Diagnostic Utility of a Novel Leadless Arrhythmia Monitoring Device, American Journal of Cardiology , 2013.

Technology 98

Technology Certification Arrhythmia Electrocardiogram 98

DAIC

MAY 18, 2024

Atrial fibrillation is the most common type of arrhythmia, and by 2050, up to 16 million Americans are projected to have AF 1. The Heart Rhythm Society is the international leader in science, education, and advocacy for cardiac arrhythmia professionals and patients and is the primary information resource on heart rhythm disorders.

Heart Rhythm 105

Heart Rhythm Atrial Fibrillation Ablation Quality of Life 105

DAIC

JUNE 11, 2024

Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure. Until recently, therapeutic options for people with tricuspid and mitral valve disorders have been limited to symptom relief or high-risk surgery.

Tricuspid 111

Tricuspid Bicuspid/Mitral Heart Valves Innovation 111

DAIC

JANUARY 18, 2024

We have long known that pulsed field ablation could open up an entirely new frontier in how we treat people battling the most complex cardiac arrhythmias. But like any innovation, early solutions have not been able to fully capitalize on those potential benefits," said Professor Prash Sanders, M.B.B.S.,

Heart Rhythm 105

Heart Rhythm Ablation AFIB Chest Pain 105

DAIC

FEBRUARY 7, 2024

CTA and the ACC recognize there is strong potential for cardiac monitoring (through Consumer Cardiovascular Technology Solutions) to help identify and screen patients with Atrial Fibrillation (AFib) and related arrhythmias to alert the right clinical groups for early support and reduction in mortality rates.

Technology 116

Technology Cardiovascular Disease Best Practices AFIB 116

DAIC

DECEMBER 20, 2023

associate professor of biomedical research and translational medicine and scientific operations director at MMRI , recently published an innovative manuscript titled, Biomimetic Nanomaterials for the Immunomodulation of the Cardiosplenic Axis Post-Myocardial Infarction. McCarthy, Ph.D. McCarthy, Ph.D., Rajendran JC Bose, Ph.D.,

Heart attacks 115

Heart attacks Heart Attack Myocardial Infarction Research 115

DAIC

FEBRUARY 1, 2024

Different types of cardiovascular disease include atherosclerosis, heart failure and arrhythmias. These innovations can make it easier and more convenient for patients to manage atherosclerosis,” according to FactMR’s November 2023 market report. based on 2020 data used to compile AHA’s 2023 Statistical Update.

Cardiovascular Disease 104

Cardiovascular Disease Atherosclerosis Strokes Stroke 104

DAIC

APRIL 9, 2024

It is also published in Heart Rhythm , the official journal of the HRS, Journal of Arrhythmia , the official journal of the APHRS, and Journal of Interventional Cardiac Electrophysiology , the official journal of the LAHRS. Antiarrhythmic drugs are advised for some patients to prevent arrhythmia recurrences early after the procedure.

Atrial Fibrillation 105

Atrial Fibrillation Ablation Heart Rhythm Blood Clot 105

DAIC

JANUARY 24, 2024

The Smidt Heart Institute recently received CAROL Act funding to study the connection between ventricular arrhythmias—abnormal heartbeats that start in the heart’s two lower chambers—and an elevated risk of sudden cardiac death in patients with mitral valve disease. Patients come to us from all over the U.S. and overseas for our expertise.

Bicuspid/Mitral 105

Bicuspid/Mitral Research Heart Valves Cardiac Arrest 105

DAIC

MARCH 12, 2025

This innovative treatment represents a significant advancement over traditional thermal ablation methods and provides a more effective solution for patients. This innovative approach not only addresses that need but also improves patient outcomes, ensuring a better quality of life for those diagnosed with A-Fib.

Ablation 52

Ablation Innovation Quality of Life Atrial Fibrillation 52

DAIC

JULY 15, 2024

Health systems leveraging Guidehealth can seamlessly integrate Story Health’s program to support at-risk patients with heart conditions like heart failure, hypertension, and arrhythmia, providing better care while also reducing the total cost of care, according to a written statement detailing the deal.

Technology 105

Technology Innovation Nursing Heart Failure 105

DAIC

MARCH 28, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTec h i , announced the submission of the VARIPULSE Platform for Premarket Approval Application (PMA) to the U.S. milla1cf Thu, 03/28/2024 - 07:28 March 28, 2024 — Biosense Webster, Inc., Food & Drug Administration ( FDA ).

Atrial Fibrillation 110

Atrial Fibrillation AFIB Ablation Pulmonary 110

Frontiers in Cardiovascular Medicine

JANUARY 15, 2024

Despite the benefits of CA, a significant proportion of patients suffer a recurrence; hence, there is scope to potentially improve outcomes through technical innovations such as ablation index (AI) guidance during AF ablation. of patients remaining free from atrial arrhythmia at 1 year and 72.3% Age >75 years ( p  = 0.02, HR: 2.7,

Ablation 64

Ablation Atrial Fibrillation BMI Arrhythmia 64

MIBHS

JANUARY 31, 2025

Risk Reduction Data from wearables can identify potential risks, such as undiagnosed arrhythmias or hypertension, allowing healthcare teams to address these issues before surgery. By embracing this innovative approach, you can pave the way for a healthier heart and a brighter future.

Heart Rhythm 52

Heart Rhythm Technology AFIB Exercise 52

DAIC

MARCH 1, 2024

Other Cedars-Sinai investigators who worked on the Circulation: Arrhythmia and Electrophysiology study include Bryan Bednarski; Harpriya Chugh; Habiba Aziz; Hoang Nhat Pham, MD; Arayik Sargsyan, MD; Audrey Uy-Evanado, MD; Damini Dey, PhD; and Kyndaron Reinier, PhD.

Cardiac Arrest 111

Cardiac Arrest Electrocardiogram Defibrillator Electrophysiology 111

DAIC

JULY 16, 2024

AFib is the most common type of irregular heart rhythm or arrhythmia. Individuals with potential arrhythmia episodes or a history of irregular rhythms can now track AFib closely and seek early intervention. UltraSignal will help fuel more customization and innovation in health.

AFIB 105

AFIB Technology Heart Rhythm Arrhythmia 105

HeartRhythm

AUGUST 27, 2024

The same holds true for the adoption of artificial intelligence (AI) by clinical cardiac electrophysiology.

Electrophysiology 40

Electrophysiology Technology Innovation Arrhythmia 40

Frontiers in Cardiovascular Medicine

DECEMBER 18, 2023

Background Cryoballoon ablation (CBA) and laser balloon ablation (LBA) are two innovative ways for the treatment of atrial fibrillation (AF). This study aimed to evaluate the efficacy and safety of cryoballoon ablation and laser balloon ablation in patients with AF. LBA presented a lower acute PVI rate per patients (CBA 97.0%

Atrial Fibrillation 64

Atrial Fibrillation Ablation Innovation Arrhythmia 64

HeartRhythm

APRIL 30, 2024

Loss-of-function SCN5A channelopathies, such as Brugada syndrome (BrS), are cardiac disorders marked by diminished sodium current (INa), conduction slowing, and lethal arrhythmias.

Pharmacology 40

Pharmacology Defibrillator Innovation Arrhythmia 40

HeartRhythm

MARCH 26, 2024

Dr Wilkoff was an innovator in the field of cardiac implantable electronic devices (CIEDs). Wilkoff, MD, one of the most impactful and pioneering members of the Heart Rhythm Society (HRS).

Heart Rhythm 45

Heart Rhythm Electrophysiology Innovation Technology 45

Heart 2023 Conference

JANUARY 17, 2024

This institute is dedicated to pioneering research, innovation, and the development of clinically effective techniques for addressing various heart conditions. Koonlawee Nademanee, Director of the Bumrungrad Heart Institute in Thailand, have spearheaded the establishment of a world-class heart institute.

Congenital Heart Disease 49

Congenital Heart Disease Coronary Artery Disease Heart Transplant Transplant 49

DAIC

JANUARY 19, 2024

Chugh’s leadership in arrhythmia research and care is extraordinary,” said Eduardo Marbán, MD, PhD , executive director of the Smidt Heart Institute. Chugh is widely regarded among our electrophysiology community as one of our most innovative, dedicated and talented researchers.

Cardiac Arrest 105

Cardiac Arrest Heart Rhythm Electrophysiology Sudden Cardiac Death 105

DAIC

FEBRUARY 2, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , revealed findings from a company-funded study of real-world data. AFib is the most common type of cardiac arrhythmia and affects more than 6 million people in the United States and nearly 38 million people worldwide.2,3

Ablation 105

Ablation Atrial Fibrillation AFIB Heart Rhythm 105

DAIC

DECEMBER 22, 2023

David Newton , Clinical Cardiac Electrophysiologist at Memorial Health University Physicians Heart Care and Dr. Andrea Natale , Executive Medical Director at T exas Cardiac Arrhythmia Institute, St. David’s Medical Center. Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib.

Atrial Fibrillation 59

Atrial Fibrillation AFIB Ablation Heart Rhythm 59

DAIC

MARCH 5, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation ( AF ) using pulsed field ablation (PFA). [ii]

Ablation 59

Ablation Atrial Fibrillation Atrial Flutter Pulmonary 59

Journal of Cardiovascular Electrophysiology

OCTOBER 3, 2024

Abstract Introduction Pulsed field ablation (PFA) has emerged as an innovative therapy for cardiac arrhythmias. Infusion and uptake of calcium chloride during pulsed field ablation leads to greater irreversible electroporation and larger myocardial ablation lesions.

Ablation 45

Ablation Innovation Arrhythmia Research 45

DAIC

JUNE 11, 2024

Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure. Until recently, therapeutic options for people with tricuspid and mitral valve disorders have been limited to symptom relief or high-risk surgery.

Tricuspid 52

Tricuspid Bicuspid/Mitral Heart Valves Innovation 52

Journal of Cardiovascular Electrophysiology

JANUARY 24, 2025

ABSTRACT Background Pulsed-field ablation (PFA) is an innovative non-thermal method for arrhythmia treatment. The efficacy of various PFA configurations in relation to contact force (CF) has not been well-studied in vivo.

Ablation 40

Ablation Innovation Arrhythmia Article 40

Wellnest

JUNE 19, 2023

With the continued evolution of AI, it is now being introduced in cardiac healthcare, promising opportunities for innovation and advancements in cardiovascular medicine. Alternatively, it also helps enhance arrhythmia management with coronary artery disease. For instance: 1. It improves the prediction model for myocardial scar mass.

Technology 52

Technology Cardiac Arrest Innovation Coronary Artery Disease 52

MIBHS

SEPTEMBER 15, 2023

Among these innovations, minimally invasive cardiac surgery stands out as a game-changer, offering numerous benefits over traditional open-heart surgery. Due to the prevalence of cardiovascular disease, there are continuous advancements in cardiac surgery techniques. This reduced risk enhances the overall safety profile of these procedures.

Open-Heart Surgery 52

Open-Heart Surgery Coronary Artery Bypass Graft Cardiovascular Disease Innovation 52

GEMMS

MAY 22, 2024

In this article, we will explore the top 10 trends shaping the future of cardiovascular medicine, highlighting the innovative technologies and approaches that are revolutionizing the field. Innovative algorithms analyze gene biomarkers to provide predictive insights and personalized patient therapy.

Heart Disease 52

Heart Disease Blood Pressure Technology Innovation 52